What is the current valuation of the Helicobacter Pylori Diagnostic Market?

The market valuation reached 2.22 USD Billion in 2024. Read More

What is the projected market size for the Helicobacter Pylori Diagnostic Market by 2035?

The market is expected to grow to 3.505 USD Billion by 2035. Read More

What is the expected CAGR for the Helicobacter Pylori Diagnostic Market during the forecast period?

The market is projected to experience a CAGR of 4.24% from 2025 to 2035. Read More

Which companies are considered key players in the Helicobacter Pylori Diagnostic Market?

Key players include Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific, among others. Read More

What are the main methodologies used in Helicobacter Pylori diagnostics?

The primary methodologies include Non-Invasive Tests, Invasive Tests, and Serological Tests. Read More

How do Non-Invasive Tests perform in terms of market valuation?

Non-Invasive Tests had a valuation of 0.89 USD Billion in 2024 and are projected to reach 1.45 USD Billion by 2035. Read More

What is the market performance of Breath Tests in the Helicobacter Pylori Diagnostic Market?

Breath Tests are expected to grow from 0.6 USD Billion in 2024 to 1.0 USD Billion by 2035. Read More

Which end-user segment shows the highest market valuation in 2024?

Hospitals led the end-user segment with a valuation of 0.89 USD Billion in 2024. Read More

What applications are driving growth in the Helicobacter Pylori Diagnostic Market?

Key applications include Diagnosis, Treatment Monitoring, and Epidemiological Studies. Read More

What is the projected growth for the Diagnostic Laboratories segment by 2035?

The Diagnostic Laboratories segment is anticipated to grow from 0.66 USD Billion in 2024 to 1.05 USD Billion by 2035. Read More

What is the expected market size of the Global Helicobacter Pylori Diagnostic Market in 2024?

The Global Helicobacter Pylori Diagnostic Market is expected to be valued at 2.13 USD Billion in 2024. Read More

What will be the market size of the Global Helicobacter Pylori Diagnostic Market in 2035?

The market is projected to reach a value of 3.5 USD Billion by 2035. Read More

What is the expected CAGR for the Global Helicobacter Pylori Diagnostic Market from 2025 to 2035?

The market is expected to grow at a CAGR of 4.62% during the forecast period from 2025 to 2035. Read More

Which region is expected to dominate the Global Helicobacter Pylori Diagnostic Market by 2035?

North America is projected to hold the largest market share, reaching a valuation of 1.35 USD Billion by 2035. Read More

What is the projected market size for Non-Invasive Tests in the Global Helicobacter Pylori Diagnostic Market by 2035?

The Non-Invasive Tests segment is expected to be valued at 1.3 USD Billion by 2035. Read More

Who are the key players in the Global Helicobacter Pylori Diagnostic Market?

Major players include Meridian Bioscience, Thermo Fisher Scientific, Hologic, and Abbott Laboratories among others. Read More

What is the estimated market size for Invasive Tests by 2035?

The Invasive Tests segment is projected to reach a market size of 0.7 USD Billion by 2035. Read More

How much is the Breath Tests segment expected to be worth in 2035?

The Breath Tests segment is expected to be valued at 0.5 USD Billion in 2035. Read More

What is the projected market growth for the Asia-Pacific region by 2035?

The Asia-Pacific region is estimated to grow to a market size of 0.7 USD Billion by 2035. Read More

What is the expected revenue for Serology Tests in the Global Helicobacter Pylori Diagnostic Market by 2035?

Serology Tests are projected to reach a market value of 0.8 USD Billion by 2035. Read More

Helicobacter Pylori Diagnostic Market

ID: MRFR/MED/40930-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Global Helicobacter Pylori Diagnostic Market Research Report By Methodology (Non-Invasive Tests, Invasive Tests, Serological Tests, Urea Breath Tests, Endoscopic Biopsy), By Test Type (Antigen Test, Breath Test, Endoscopy, Polymerase Chain Reaction, Serology Test), By End User (Hospitals, Diagnostic Laboratories, Clinics, Home Care Settings), By Application (Diagnosis, Treatment Monitoring, Epidemiological Studies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Helicobacter Pylori Diagnostic Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.24%

2024 Market Size$ 2.22 Billion

2025 Market Size$ 2.31 Billion

2035 Market Size$ 3.5 Billion

Key Players

Abbott Laboratories

Roche Diagnostics

Thermo Fisher Scientific

Siemens Healthineers

Becton Dickinson and Company

Hologic

Trends

Rise of Non-Invasive Testing Methods
Integration of Advanced Technologies
Increased Focus on Preventive Healthcare

Opportunities

Increase in Healthcare Expenditure
Advancements in Diagnostic Technologies
Rising Awareness of Gastrointestinal Health

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Methodology (USD Billion)
  1. 4.1.1 Non-Invasive Tests
  2. 4.1.2 Invasive Tests
  3. 4.1.3 Serological Tests
  4. 4.1.4 Urea Breath Tests
  5. 4.1.5 Endoscopic Biopsy
2. 4.2 Healthcare, BY Test Type (USD Billion)
  1. 4.2.1 Antigen Test
  2. 4.2.2 Breath Test
  3. 4.2.3 Endoscopy
  4. 4.2.4 Polymerase Chain Reaction
  5. 4.2.5 Serology Test
3. 4.3 Healthcare, BY End User (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Laboratories
  3. 4.3.3 Clinics
  4. 4.3.4 Home Care Settings
4. 4.4 Healthcare, BY Application (USD Billion)
  1. 4.4.1 Diagnosis
  2. 4.4.2 Treatment Monitoring
  3. 4.4.3 Epidemiological Studies
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Diagnostics (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Siemens Healthineers (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Becton Dickinson and Company (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hologic, Inc. (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Bio-Rad Laboratories, Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Ortho Clinical Diagnostics (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY METHODOLOGY
4. 6.4 US MARKET ANALYSIS BY TEST TYPE
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 US MARKET ANALYSIS BY APPLICATION
7. 6.7 CANADA MARKET ANALYSIS BY METHODOLOGY
8. 6.8 CANADA MARKET ANALYSIS BY TEST TYPE
9. 6.9 CANADA MARKET ANALYSIS BY END USER
10. 6.10 CANADA MARKET ANALYSIS BY APPLICATION
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY METHODOLOGY
13. 6.13 GERMANY MARKET ANALYSIS BY TEST TYPE
14. 6.14 GERMANY MARKET ANALYSIS BY END USER
15. 6.15 GERMANY MARKET ANALYSIS BY APPLICATION
16. 6.16 UK MARKET ANALYSIS BY METHODOLOGY
17. 6.17 UK MARKET ANALYSIS BY TEST TYPE
18. 6.18 UK MARKET ANALYSIS BY END USER
19. 6.19 UK MARKET ANALYSIS BY APPLICATION
20. 6.20 FRANCE MARKET ANALYSIS BY METHODOLOGY
21. 6.21 FRANCE MARKET ANALYSIS BY TEST TYPE
22. 6.22 FRANCE MARKET ANALYSIS BY END USER
23. 6.23 FRANCE MARKET ANALYSIS BY APPLICATION
24. 6.24 RUSSIA MARKET ANALYSIS BY METHODOLOGY
25. 6.25 RUSSIA MARKET ANALYSIS BY TEST TYPE
26. 6.26 RUSSIA MARKET ANALYSIS BY END USER
27. 6.27 RUSSIA MARKET ANALYSIS BY APPLICATION
28. 6.28 ITALY MARKET ANALYSIS BY METHODOLOGY
29. 6.29 ITALY MARKET ANALYSIS BY TEST TYPE
30. 6.30 ITALY MARKET ANALYSIS BY END USER
31. 6.31 ITALY MARKET ANALYSIS BY APPLICATION
32. 6.32 SPAIN MARKET ANALYSIS BY METHODOLOGY
33. 6.33 SPAIN MARKET ANALYSIS BY TEST TYPE
34. 6.34 SPAIN MARKET ANALYSIS BY END USER
35. 6.35 SPAIN MARKET ANALYSIS BY APPLICATION
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY METHODOLOGY
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY METHODOLOGY
42. 6.42 CHINA MARKET ANALYSIS BY TEST TYPE
43. 6.43 CHINA MARKET ANALYSIS BY END USER
44. 6.44 CHINA MARKET ANALYSIS BY APPLICATION
45. 6.45 INDIA MARKET ANALYSIS BY METHODOLOGY
46. 6.46 INDIA MARKET ANALYSIS BY TEST TYPE
47. 6.47 INDIA MARKET ANALYSIS BY END USER
48. 6.48 INDIA MARKET ANALYSIS BY APPLICATION
49. 6.49 JAPAN MARKET ANALYSIS BY METHODOLOGY
50. 6.50 JAPAN MARKET ANALYSIS BY TEST TYPE
51. 6.51 JAPAN MARKET ANALYSIS BY END USER
52. 6.52 JAPAN MARKET ANALYSIS BY APPLICATION
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY METHODOLOGY
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
57. 6.57 MALAYSIA MARKET ANALYSIS BY METHODOLOGY
58. 6.58 MALAYSIA MARKET ANALYSIS BY TEST TYPE
59. 6.59 MALAYSIA MARKET ANALYSIS BY END USER
60. 6.60 MALAYSIA MARKET ANALYSIS BY APPLICATION
61. 6.61 THAILAND MARKET ANALYSIS BY METHODOLOGY
62. 6.62 THAILAND MARKET ANALYSIS BY TEST TYPE
63. 6.63 THAILAND MARKET ANALYSIS BY END USER
64. 6.64 THAILAND MARKET ANALYSIS BY APPLICATION
65. 6.65 INDONESIA MARKET ANALYSIS BY METHODOLOGY
66. 6.66 INDONESIA MARKET ANALYSIS BY TEST TYPE
67. 6.67 INDONESIA MARKET ANALYSIS BY END USER
68. 6.68 INDONESIA MARKET ANALYSIS BY APPLICATION
69. 6.69 REST OF APAC MARKET ANALYSIS BY METHODOLOGY
70. 6.70 REST OF APAC MARKET ANALYSIS BY TEST TYPE
71. 6.71 REST OF APAC MARKET ANALYSIS BY END USER
72. 6.72 REST OF APAC MARKET ANALYSIS BY APPLICATION
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY METHODOLOGY
75. 6.75 BRAZIL MARKET ANALYSIS BY TEST TYPE
76. 6.76 BRAZIL MARKET ANALYSIS BY END USER
77. 6.77 BRAZIL MARKET ANALYSIS BY APPLICATION
78. 6.78 MEXICO MARKET ANALYSIS BY METHODOLOGY
79. 6.79 MEXICO MARKET ANALYSIS BY TEST TYPE
80. 6.80 MEXICO MARKET ANALYSIS BY END USER
81. 6.81 MEXICO MARKET ANALYSIS BY APPLICATION
82. 6.82 ARGENTINA MARKET ANALYSIS BY METHODOLOGY
83. 6.83 ARGENTINA MARKET ANALYSIS BY TEST TYPE
84. 6.84 ARGENTINA MARKET ANALYSIS BY END USER
85. 6.85 ARGENTINA MARKET ANALYSIS BY APPLICATION
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY METHODOLOGY
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY METHODOLOGY
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY METHODOLOGY
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
99. 6.99 REST OF MEA MARKET ANALYSIS BY METHODOLOGY
100. 6.100 REST OF MEA MARKET ANALYSIS BY TEST TYPE
101. 6.101 REST OF MEA MARKET ANALYSIS BY END USER
102. 6.102 REST OF MEA MARKET ANALYSIS BY APPLICATION
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY METHODOLOGY, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY METHODOLOGY, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.2.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.3.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.3.4 BY APPLICATION, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.4.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.4.4 BY APPLICATION, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.5.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.5.4 BY APPLICATION, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.6.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.6.4 BY APPLICATION, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.7.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.7.4 BY APPLICATION, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.8.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.8.4 BY APPLICATION, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.9.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.9.4 BY APPLICATION, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.10.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.10.4 BY APPLICATION, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.11.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.11.4 BY APPLICATION, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.12.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.12.4 BY APPLICATION, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.13.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.13.4 BY APPLICATION, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.14.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.14.4 BY APPLICATION, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.15.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.15.4 BY APPLICATION, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.16.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.16.4 BY APPLICATION, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.17.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.17.4 BY APPLICATION, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.18.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.18.4 BY APPLICATION, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.19.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.19.4 BY APPLICATION, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.20.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.20.4 BY APPLICATION, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.21.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.21.4 BY APPLICATION, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.22.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.22.4 BY APPLICATION, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.23.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.23.4 BY APPLICATION, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.24.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.24.4 BY APPLICATION, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.25.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.25.4 BY APPLICATION, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.26.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.26.4 BY APPLICATION, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.27.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.27.4 BY APPLICATION, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.28.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.28.4 BY APPLICATION, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.29.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.29.4 BY APPLICATION, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.30.2 BY TEST TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.30.4 BY APPLICATION, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Helicobacter Pylori Diagnostic Market Segmentation

Helicobacter Pylori Diagnostic Market By Methodology (USD Billion, 2025-2035)

Non-Invasive Tests
Invasive Tests
Serological Tests
Urea Breath Tests
Endoscopic Biopsy

Helicobacter Pylori Diagnostic Market By Test Type (USD Billion, 2025-2035)

Antigen Test
Breath Test
Endoscopy
Polymerase Chain Reaction
Serology Test

Helicobacter Pylori Diagnostic Market By End User (USD Billion, 2025-2035)

Hospitals
Diagnostic Laboratories
Clinics
Home Care Settings

Helicobacter Pylori Diagnostic Market By Application (USD Billion, 2025-2035)

Diagnosis
Treatment Monitoring
Epidemiological Studies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”